Article Tools/Herramientas de artículos
+ Larger Font/Fuente más grande | - Smaller Font/Fuente más pequeña






Scientific News Thermo Fisher Scientific Profit, Revenue Hurt By Sales Struggles At 2 Key Units

Search Related Content

Sorry, Your Requested Page Was Not Found. Greetings! We apologize for the inconvenience, but the page, Scientific News Thermo Fisher Scientific Profit, Revenue Hurt By Sales Struggles At 2 Key Units is no longer available. Please use our search box below to find related content and browse the list of related news stories. Depending on the topic, news articles are deleted 3-18 months after their creation date. We prefer to keep content fresh and current, rather than holding onto outdated news. Thanks for visiting today.
Search RobinsPost News & Noticias


Scientific News Thermo Fisher Scientific Profit, Revenue Hurt By Sales Struggles At 2 Key Units | RobinsPost News & Noticias

Examining the Future: Thermo Fisher Scientific's Earnings Outlook


Analysts estimate that Thermo Fisher Scientific will report an earnings per share (EPS) of $5.50. The announcement from Thermo Fisher Scientific is eagerly anticipated, with investors seeking news of ... Read More

Thermo Fisher's Upbeat Earnings Suggest Worst Is Over For Scientific Tools Sector, Analyst Says


Thermo Fisher Scientific reports Q3 2025 adjusted earnings of $5.79 per share, sales of $11.12 billion and raised its full-year guidance. Read More

Countdown to Thermo Fisher (TMO) Q3 Earnings: Wall Street Forecasts for Key Metrics


In its upcoming report, Thermo Fisher Scientific (TMO) is predicted by Wall Street analysts to post quarterly earnings of $5.50 per share, reflecting an increase of 4.2% compared to the same period ... Read More

Thermo Fisher Scientific: More Upside Likely As Headwinds Continue To Fade And Valuation Still Attractive


Thermo Fisher's stock offers attractive upside, backed by pharma recovery, margin expansion, and AI-driven efficiency. Read here for more on TMO stock. Read More

Thermo Fisher raises 2025 guidance to $44.2B revenue and $22.84 EPS amid strong pharma and biotech momentum


Earnings Call Insights: Thermo Fisher Scientific Inc. (TMO) Q2 2025 CEO Marc N. Casper highlighted "excellent operational performance in the quarter, reflecting active management of our company and ... Read More

Thermo Fisher Scientific: Now Fairly Valued Considering Growth Outlook (Rating Downgrade)


Thermo Fisher (TMO) lifts 2025 outlook with strong sales and margin gains. Fair value estimate near $570 provides a limited margin of safety. See more. Read More

Thermo Scientific 3Q Revenue Rises, Boosted by Life Sciences Business


Thermo Scientific recorded higher third-quarter sales on the back of growth in its life sciences business. The scientific services company reported net income of $1.62 billion, or $4.27 a share, ... Read More


Blow Us A Whistle


Comments (Whistles) Designed By Disqus